Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXELON CORP Director's Dealing 2022

Jan 10, 2022

30044_dirs_2022-01-10_56e1abc8-40cd-46d7-bb6e-78d2c3c7f5c4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELON CORP (EXC)
CIK: 0001109357
Period of Report: 2022-01-06

Reporting Person: MCHUGH JAMES (EVP & Chief Commercial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-01-06 Common Stock M 12874 Acquired 38472 Direct
2022-01-06 Common Stock F 3792 $56.73 Disposed 34680 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-01-06 2019 Restricted Stock Units $0 M 4305 Disposed Common Stock (4305) Direct
2022-01-06 2020 Restricted Stock Units $0 M 4181 Disposed Common Stock (4181) Direct
2022-01-06 2021 Restricted Stock Units $0 M 4388 Disposed Common Stock (4388) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Deferred Compensation Phantom Shares $0 Common Stock (2213) 2213 Direct
Restricted Stock Unit Award 4/5/2021 $0 Common Stock (20462) 20462 Direct

Footnotes

F1: Common shares acquired through conversion of previously awarded and vested restricted stock units (RSUs) under the Exelon Long Term Incentive Plan.

F2: Vesting of previously granted restricted stock unit (RSU) awarded under Exelon Long Term Incentive Plan. Awards granted annually to vest in 1/3 increments at the January or February meetings of the Compensation Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting. RSUs accrue quarterly dividend equivalents in the form of additional RSUs representing common stock dividends as approved by the Board, which vest on the same schedule as the underlying RSU award.

F3: The RSU award accrued 30 additional shares during 2021 from the date that Mr. McHugh became a reporting person through automatic dividend reinvestment.

F4: The RSU award accrued 59 additional shares during 2021 from the date that Mr. McHugh became a reporting person through automatic dividend reinvestment.

F5: The RSU award accrued 93 additional shares during 2021 from the date that Mr. McHugh became a reporting person through automatic dividend reinvestment.

F6: Phantom share equivalents held in the Exelon stock fund within the Exelon Deferred Compensation Plan, which is multi-fund, non-qualified deferred compensation plan. The share equivalents within the fund will be settled in cash upon the reporting person's separation from the company for any reason. The balance includes 40 additional share equivalents acquired during 2021 from the date that Mr. McHugh became a reporting person through automatic dividend reinvestment.

F7: Restricted stock unit award granted pursuant to the Exelon LTI plan. The award accrues quarterly dividend equivalents in the form of additional RSUs representing common stock dividends as approved by the Board. All shares will cliff vest on April 5, 2025. Balance includes 144 additional shares accrued during 2021 from the date that Mr. McHugh became a reporting person through automatic dividend reinvestment.